
Personalized and Predictive Insulin Dosing Across the Healthcare Enterprise
Monarch Medical Technologies, the maker of the EndoTool Glucose Management System, is the leading provider of precision insulin dosing technology for improved patient outcomes.
"*" indicates required fields

Precision Medicine for Inpatient Glycemic Management
Proven, patented algorithms that model, predict and adapt dosing recommendations to each patient and their individual response to insulin, for more precise, safer therapy.
Hospitals using EndoTool IV have demonstrated better patient outcomes, including:
See Why Customers Love EndoTool

WHY GLYCEMIC MANAGEMENT MATTERS
Learn why adopting best practices in glycemic management is vital to high-quality patient care.
ENDOTOOL EVIDENCE LIBRARY
Explore clinical research studies demonstrating the safety and efficacy of EndoTool.

Spotlight
Check out the latest news and resources from our internal teams and our users!

Literature
Selecting Optimal Glucose Ranges in the ICU
Explore our white paper to see the recent evidence behind personalized hyperglycemia management and the effectiveness of EndoTool in reducing hypoglycaemia incidents.
EVIDENCE

Four-fold Decrease in Hypoglycemic Events: Easing Nursing Burden and Improving Patient Safety at UPMC
UPMC demonstrated a decreased time on insulin infusion, reduced overall LOS, improved time to goal, decreased number of glucose checks and a four-fold decrease in hypoglycemic events.
Video

Spectrum Health Improves Inpatient Glucose Control with EndoTool
In this video, clinical leaders at Spectrum Health describe why they adopted a computer-based approach, the multidisciplinary team that evaluated options, and ultimately how EndoTool has helped improve patient care and essentially eliminate hypoglycemia.